Reference Cluster Normalization Improves Detection of Frontotemporal Lobar Degeneration by Means of FDG-PET

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Dukart, Juergen ^a,c   Perneczky, Robert ^e,f,i   Förster, Stefan ^f   Barthel, Henryk ^b   Diehl Schmid, Janine ^e,f   Draganski, Bogdan ^a,d   Obrig, Hellmuth ^b,c   Santarnecchi, Emiliano ^g   Drzezga, Alexander ^f   Fellgiebel, Andreas ^h   Frackowiak, Richard ^a   Kurz, Alexander ^e,f   Müller, Karsten ^c   Sabri, Osama ^b   Schroeter, Matthias L ^b,c,e   Yakushev, Igor ^f,h  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e Consortium for Frontotemporal Lobar Degeneration ^*  (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF SIENA   (Italy)

^h UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BRAIN REGION; CEREBELLUM; CEREBRAL GLOBAL MEAN; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG UPTAKE; EARLY DIAGNOSIS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGE PROCESSING; MALE; NORMAL VALUE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; REFERENCE CLUSTER NORMALIZATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENSORIMOTOR CORTEX;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84874549006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055415     Document Type: Article

References (47)

1. Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, et al. (2008) Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res 164: 143-153.
2. Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, et al. (2010) Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 49: 1490-1495.
3. Minoshima S, Frey KA, Foster NL, Kuhl DE, (1995) Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 19: 541-547.
4. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, et al. (1998) Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. J Nucl Med 39: 293-298.
5. Schroeter ML, Stein T, Maslowski N, Neumann J, (2009) Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 47: 1196-1206.
6. Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, et al. (2009) SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 44: 43-50.
7. Borghammer P, Cumming P, Østergaard K, Gjedde A, Rodell A, et al. (2012) Cerebral oxygen metabolism in patients with early Parkinson's disease. J Neurol Sci 313: 123-128.
8. Borghammer P, Hansen SB, Eggers C, Chakravarty M, Vang K, et al. (2012) Glucose metabolism in small subcortical structures in Parkinson's disease. Acta Neurol Scand 125: 303-310.
9. Borghammer P, Aanerud J, Gjedde A, (2009) Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization. Neuroimage 46: 981-988.
10. Ibach B, Poljansky S, Marienhagen J, Sommer M, Männer P, et al. (2004) Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease. Neuroimage 23: 739-743.
11. Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, et al. (2006) Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 169: 1343-1352.
12. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC, (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82: 476-486.
13. Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, et al. (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130: 2616-2635.
14. Kipps CM, Hodges JR, Fryer TD, Nestor PJ, (2009) Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. Brain 132: 2566-2578.
15. Piguet O, Hornberger M, Mioshi E, Hodges JR, (2011) Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol 10: 162-172.
16. Schroeter ML, Neumann J, (2011) Combined Imaging Markers Dissociate Alzheimer's Disease and Frontotemporal Lobar Degeneration - An ALE Meta-Analysis. Front Aging Neurosci 3: 10.
17. Dukart J, Mueller K, Horstmann A, Barthel H, Möller HE, et al. (2011) Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of Dementia. PLoS One 6: e18111.
18. Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, et al. (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 49: 390-398.
19. Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Riemenschneider M, et al. (2007) Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging 28: 42-50.
20. Diehl J, Grimmer T, Drzezga A, Riemenschneider M, Forstl H, et al. (2004) Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol Aging 25: 1051-1056.
21. Sadeghi N, Foster NL, Wang AY, Minoshima S, Lieberman AP, et al. (2008) Automatic classification of Alzheimer's disease vs. Frontotemporal dementia: A spatial decision tree approach with FDG-PET. 2008 Ieee International Symposium on Biomedical Imaging: From Nano to Macro, Vols 1-4: 408-411.
22. Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, et al. (2005) 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 46: 233-239.
23. Schroeter ML, Raczka K, Neumann J, Yves von Cramon D, (2007) Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects. Neuroimage 36: 497-510.
24. Schroeter ML, Raczka K, Neumann J, von Cramon DY, (2008) Neural networks in frontotemporal dementia - a meta-analysis. Neurobiol Aging 29: 418-426.
25. Dukart J, Mueller K, Barthel H, Villringer A, Sabri O, et al. (2012) Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI. Psychiatry Res: 10.1016/j.pscychresns.2012.1004.1007.
26. Harvey RJ, Skelton-Robinson M, Rossor MN, (2003) The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 74: 1206-1209.
27. Borghammer P, Cumming P, Aanerud J, Förster S, Gjedde A, (2009) Subcortical elevation of metabolism in Parkinson's disease - a critical reappraisal in the context of global mean normalization. Neuroimage 47: 1514-1521.
28. Berti V, Polito C, Borghammer P, Ramat S, Mosconi L, et al. (2012) Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease. Q J Nucl Med Mol Imaging 56: 299-308.
29. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554.
30. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, et al. (2006) Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry 14: 139-144.
31. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, et al. (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273-289.
32. Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, et al. (2004) MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 63: 2332-2340.
33. Samuraki M, Matsunari I, Chen WP, Yajima K, Yanase D, et al. (2007) Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur J Nucl Med Mol Imaging 34: 1658-1669.
34. Maldjian JA, Laurienti PJ, Burdette JH, (2004) Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 21: 450-455.
35. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH, (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233-1239.
36. Silverman DH, (2004) Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 45: 594-607.
37. Aguirre GK, Zarahn E, D'Esposito M, (1998) The inferential impact of global signal covariates in functional neuroimaging analyses. Neuroimage 8: 302-306.
38. Gavrilescu M, Shaw ME, Stuart GW, Eckersley P, Svalbe ID, et al. (2002) Simulation of the effects of global normalization procedures in functional MRI. Neuroimage 17: 532-542.
39. Perneczky R, Diehl-Schmid J, Förstl H, Drzezga A, May F, et al. (2008) Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations. Eur J Nucl Med Mol Imaging 35: 605-610.
40. Poljansky S, Ibach B, Hirschberger B, Männer P, Klünemann H, et al. (2011) A visual [18F] FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration. Eur Arch Psychiatry Clin Neurosci 261: 433-446.
41. Santens P, De Bleecker J, Goethals P, Strijckmans K, Lemahieu I, et al. (2001) Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis. Eur Neurol 45: 19-27.
42. Rostomian AH, Madison C, Rabinovici GD, Jagust WJ, (2011) Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med 52: 173-179.
43. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
44. Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, et al. (2006) HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 60: 314-322.
45. Tien RD, Ashdown BC, (1992) Crossed cerebellar diaschisis and crossed cerebellar atrophy: correlation of MR findings, clinical symptoms, and supratentorial diseases in 26 patients. AJR Am J Roentgenol 158: 1155-1159.
46. Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, et al. (2010) Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 9: 149-158.
47. Klöppel S, Abdulkadir A, Jack CR, Koutsouleris N, Mourão-Miranda J, et al. (2012) Diagnostic neuroimaging across diseases. Neuroimage 61: 457-463.